Guideline on the clinical investigation of human plasma derived von Willebrand factor products

Information

Type

International scientific guidelines adopted in Australia

Regulated products

Medical Devices

Topics

Advertising, Biological Medicines, Listed Medicines, Prescription Medicines

Published

July 18, 2024

Last updated

July 18, 2024

Description

We have adopted this International Scientific Guideline - CPMP/BPWG/220/02

Organization

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed